Author Archives: Syndicated Content

By Catarina Demony and Gabriel Araujo LISBON (Reuters) - Trying to lure back wary foreign investors, Brazil's President Luiz Inacio Lula da Silva vowed on Monday to restore stability and credibility, ...

By Gabriela Baczynska and John Irish BRUSSELS/PARIS (Reuters) - Italy offered Tunisia a prospect of money in exchange for economic and political reforms as European Union foreign ministers discussed o...

(Reuters) - Bluebird bio Inc said on Monday it has submitted a marketing application to the U.S. Food and Drug Administration for its gene therapy to treat sickle cell disease. The announcement comes ...

By Hilary Russ NEW YORK (Reuters) - The sandwich chain Subway said on Monday that its global comparable sales were 12.1% higher in the first quarter and that guest visits rose, driven in part by resta...

(Reuters) - Foghorn Therapeutics Inc said on Monday it has paused enrollment in an early-stage study of the company's experimental cancer drug due to safety concerns. (Reporting by Khushi Mandowara in...

By Nichola Groom (Reuters) - U.S. President Joe Biden's plan to challenge China's dominance in solar panel manufacturing hinges in large part on rules his administration will soon release defining wha...

(Reuters) -Coca-Cola Co beat Wall Street estimates for quarterly revenue and profit on Monday, as demand for its sodas remained resilient in the face of multiple price increases taken to combat higher...

BERLIN (Reuters) -Industrial action grounded dozens of flights at two major German airports on Monday as security workers and ground services employees in the capital, Berlin, and in Hamburg held a on...

LONDON (Reuters) - Britain on Monday announced 100 million pounds ($124.5 million) in initial funding for a taskforce to help develop foundation models - a type of artificial intelligence used by chat...

(Reuters) - Eli Lilly and Co will sell its low blood sugar drug Baqsimi to Amphastar Pharmaceuticals for over $500 million in cash, the two companies said on Monday. Amphastar will pay $500 million at...